Europe is set for a wave of long-awaited policy action in the biotech and life sciences sectors – including through a European Startup and Scaleup Strategy, a Life Sciences Strategy, and a Biotech Act.
Marking Poland’s Council Presidency of the European Union, EuropaBio National Associations Council is excited to bring you the latest edition of its usual Council Presidency Summit!
This time, in person in Warsaw, in an informal setting, we will explore the key elements of a successful national strategy for the life sciences sector and how Europe can better support its startups and scaleups to make them globally competitive. We will also explore how to bridge Eastern Europe and the Baltic nations with Western Europe, building a truly single market for biotech and life sciences products.
This discussion will be co-hosted with the Polish biotechnology association BioForum. It will be part of its upcoming CEBioForum event 2025.
If you wish for further information, and you will be attending CEBioForum, feel free to drop a message to José Peres at j.peres@europabio.org.
Location: CIC, Chmielna 73, Warsaw, Poland.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.